37 /100
MEDIUM RISK
Score updated Jun 11, 2026

GLUE — Monte Rosa Therapeutics, Inc. Dilution Risk Tracker

Track GLUE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLUE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GLUE.
🔔 Track GLUE — Get forecast alerts →

💹 Market Data

Market Cap$1.67B
Shares Outstanding84.48M
Float52.94M
Cash$159.86M
Debt$39.06M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 41.7% shares (2026Q1 vs prior)
191 institutional holders · 93.33M shares
#1 NEA Management Company, LLC 7.69M shares
#2 PRICE T ROWE ASSOCIATES INC /MD/ 6.72M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 6.20M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.96M
Days to Cover20.6
% of Float28.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Jun 30, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GLUE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLUE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for GLUE
📊 GLUE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GLUE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.